Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pollard

Showing results (901-910 of 992) with videos related to

Pageof 100
Sort By:
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Medicine|October 13, 2022
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infectionAlexander J Mentzer, Daniel O'Connor, Sagida Bibi, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
Cell Reports|September 28, 2017
Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive DiabetesJulie Adam, Reshma Ramracheya, Margarita V Chibalina, et al.
Plos Pathogens|November 27, 2018
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococciTaj Azarian, Patrick K Mitchell, Maria Georgieva, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Cancer Research|October 28, 2010
Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesisHouman Ashrafian, Linda O'Flaherty, Julie Adam, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
The Journal of Infection|July 3, 2018
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysisEvelyn Balsells, Ron Dagan, Inci Yildirim, et al.
Pageof 100

Showing results (901-910 of 992) with videos related to

Sort By:
Pageof 100
Nature Immunology|June 15, 2023
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19Paulina Kaplonek, Deniz Cizmeci, Gaurav Kwatra, et al.
Nature Medicine|October 13, 2022
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infectionAlexander J Mentzer, Daniel O'Connor, Sagida Bibi, et al.
The Journal of Experimental Medicine|May 25, 2016
Interferon-driven alterations of the host's amino acid metabolism in the pathogenesis of typhoid feverChristoph J Blohmke, Thomas C Darton, Claire Jones, et al.
The Lancet. Microbe|February 16, 2026
The effect of pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine on nasopharyngeal colonisation following human infection challenge with serotype 3 and serotype 6B (PREVENTING PNEUMO 2): a double-masked, randomised, controlled, phase 4 trialKonstantinos Liatsikos, Angela Hyder-Wright, Kelly Davies, et al.
Cell Reports|September 28, 2017
Fumarate Hydratase Deletion in Pancreatic β Cells Leads to Progressive DiabetesJulie Adam, Reshma Ramracheya, Margarita V Chibalina, et al.
Plos Pathogens|November 27, 2018
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococciTaj Azarian, Patrick K Mitchell, Maria Georgieva, et al.
The Lancet. Microbe|May 4, 2024
Safety, tolerability, viral kinetics, and immune correlates of protection in healthy, seropositive UK adults inoculated with SARS-CoV-2: a single-centre, open-label, phase 1 controlled human infection studySusan Jackson, Julia L Marshall, Andrew Mawer, et al.
Cancer Research|October 28, 2010
Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesisHouman Ashrafian, Linda O'Flaherty, Julie Adam, et al.
Journal of Clinical Microbiology|March 24, 2022
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCRJeremy Ratcliff, Farah Al-Beidh, Sagida Bibi, et al.
The Journal of Infection|July 3, 2018
The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysisEvelyn Balsells, Ron Dagan, Inci Yildirim, et al.
Pageof 100